Factors which the IRB should take into consideration when evaluating the adequacy of plans include the following: model of plan chosen (independent committee, monitor, the principle investigator) ...

A California-based biotech company is stealing the show on Wednesday after the company announced the data monitoring committee has recommended the continuation of its Phase 3 Sunrize study.

The Data Monitoring Committee (DMC) identified no safety concerns related to changes in ICH volumes, serious adverse events, neurological outcomes, or mortality. Bioxodes will release a second interim ...

The Independent Data Monitoring Committee (IDMC) has recommended the study continue without modifications, citing no safety concerns from the data reviewed. According to InvestingPro data ...

The Independent Data Monitoring Committee (IDMC) has recommended the study continue without modifications, citing no safety concerns from the data reviewed. According to InvestingPro data, GRI ...